
Envisioning a world where 3-D printers make everything

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

MindBody getting closer to profitability

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Yardi acquires coworking platform Wun Systems

Goleta real estate management company Yardi Systems announced that it has acquired Wun Systems, a coworking and workspace management platform based in Los Angeles. Wun provides software, hardware and support services for more than 80,000 members, the two companies said in a news release Nov. 1. Its management, engineering and programming team will operate out Read More →
Increased sales at Teledyne boost net income

Sales for Thousand Oaks-based Teledyne rose more than 25 percent for the third quarter of 2017, boosting net income up 32.7 percent to $69 million, or $1.90 per diluted share. Aerospace and defense electronics sales rose 7.6 percent for the company, and engineered systems sales increased nearly 10 percent to $73.1 million. Sales in the Read More →
Frontier revenue dips but net losses smaller

Frontier Communications saw a slight dip in third quarter revenue but smaller net losses year-over year, the company announced Oct. 31. Revenue reached $2.25 billion, down slightly from the previous quarter and the third quarter of 2016. But the first nine months of the year saw a 6.5 percent increase in revenue over the same Read More →
Amgen buying out joint venture Kirin-Amgen for $780 million

Amgen, the biotech giant based in Thousand Oaks, announced that it would buy out joint venture Kirin-Amgen, which was created to develop white blood cell booster Neupogen among other projects, for $780 million. The joint venture holds intellectual property rights for Neupogen, Neulasta, Aranesp, Nplate and brodalumab. In addition to the cash deal, Amgen will Read More →